Chronic intermittent hypoxia augments chemoreflex control of sympathetic activity: Role of the angiotensin II type 1 receptor

Respiratory Physiology and Neurobiology

Volumn 171, Issue 1, 2010, Pages 36-45

  Marcus, Noah J ^a   Li, Yu Long ^b   Bird, Cynthia E ^c   Schultz, Harold D ^b   Morgan, Barbara J ^a,c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Angiotensin antagonist; Angiotensin II; Chemoreceptors; Oxidative stress; Superoxide

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; LOSARTAN; NEURONAL NITRIC OXIDE SYNTHASE; POTASSIUM CYANIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE GP91PHOX; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; APNEA; ARTERIAL GAS; ARTICLE; CAROTID BODY; CHEMORECEPTOR REFLEX; CHRONIC INTERMITTENT HYPOXIA; CONTROLLED STUDY; HEAT; HYPOXIA; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYMPATHETIC NERVE; SYMPATHETIC TONE;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANOXIA; APNEA; BLOOD PRESSURE; CAROTID BODY; CHEMORECEPTOR CELLS; GENE EXPRESSION REGULATION; LOSARTAN; MALE; NADPH OXIDASE; NITRIC OXIDE SYNTHASE TYPE I; OXYGEN CONSUMPTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; SUPEROXIDES; SYMPATHETIC NERVOUS SYSTEM;

EID: 77949571119     PISSN: 15699048     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resp.2010.02.003     Document Type: Article

References (51)

1. Allen A.M. Angiotensin AT1 receptor-mediated excitation of rat carotid body chemoreceptor afferent activity. J. Physiol. 510 Pt 3 (1998) 773-781
2. Bach K.B., Kinkead R., and Mitchell G.S. Post-hypoxia frequency decline in rats: sensitivity to repeated hypoxia and alpha2-adrenoreceptor antagonism. Brain Res. 817 (1999) 25-33
3. Bao G., Metreveli N., and Fletcher E.C. Acute and chronic blood pressure response to recurrent acoustic arousal in rats. Am. J. Hypertens. 12 (1999) 504-510
4. Barros R.C., Bonagamba L.G., Okamoto-Canesin R., de Oliveira M., Branco L.G., and Machado B.H. Cardiovascular responses to chemoreflex activation with potassium cyanide or hypoxic hypoxia in awake rats. Auton. Neurosci. 97 (2002) 110-115
5. Brooks D., Horner R.L., Kozar L.F., Render-Teixeira C.L., and Phillipson E.A. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J. Clin. Invest. 99 (1997) 106-109
6. Campese V.M., Ye S., and Zhong H. Downregulation of neuronal nitric oxide synthase and interleukin-1beta mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension 39 (2002) 519-524
7. Ding Y., Li Y.L., and Schultz H.D. Downregulation of carbon monoxide as well as nitric oxide contributes to peripheral chemoreflex hypersensitivity in heart failure rabbits. J. Appl. Physiol. 105 (2008) 14-23
8. Dorward P.K., Riedel W., Burke S.L., Gipps J., and Korner P.I. The renal sympathetic baroreflex in the rabbit. Arterial and cardiac baroreceptor influences, resetting, and effect of anesthesia. Circ. Res. 57 (1985) 618-633
9. Fletcher E.C., Bao G., and Li R. Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension 34 (1999) 309-314
10. Fletcher E.C., Lesske J., Behm R., Miller III C.C., Stauss H., and Unger T. Carotid chemoreceptors, systemic blood pressure, and chronic episodic hypoxia mimicking sleep apnea. J. Appl. Physiol. 72 (1992) 1978-1984
11. Fletcher E.C., Lesske J., Culman J., Miller C.C., and Unger T. Sympathetic denervation blocks blood pressure elevation in episodic hypoxia. Hypertension 20 (1992) 612-619
12. Franken P., Malafosse A., and Tafti M. Genetic determinants of sleep regulation in inbred mice. Sleep 22 (1999) 155-169
13. Gao L., Wang W., Li Y.L., Schultz H.D., Liu D., Cornish K.G., and Zucker I.H. Sympathoexcitation by central ANG II: roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM. Am. J. Physiol Heart Circ. Physiol. 288 (2005) H2271-H2279
14. Gradman A.H., Pinto R., and Kad R. Current concepts: renin inhibition in the treatment of hypertension. Curr. Opin. Pharmacol. 8 (2008) 120-126
15. Greenberg H.E., Sica A., Batson D., and Scharf S.M. Chronic intermittent hypoxia increases sympathetic responsiveness to hypoxia and hypercapnia. J. Appl. Physiol. 86 (1999) 298-305
16. Guild S.J., Barrett C.J., McBryde F.D., Van Vliet B.N., Head G.A., Burke S.L., and Malpas S.C. Quantifying sympathetic nerve activity: problems and pitfalls, the need for standardization. Exp. Physiol. 95 (2009) 41-50
17. Guyenet P.G. Neural structures that mediate sympathoexcitation during hypoxia. Respir. Physiol. 121 (2000) 147-162
18. Hedner J., Ejnell H., Sellgren J., Hedner T., and Wallin G. Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension?. J. Hypertens. Suppl. 6 (1988) S529-S531
19. Huang J., Lusina S., Xie T., Ji E., Xiang S., Liu Y., and Weiss J.W. Sympathetic response to chemostimulation in conscious rats exposed to chronic intermittent hypoxia. Respir. Physiol. Neurobiol. 166 (2009) 102-106
20. Imadojemu V.A., Mawji Z., Kunselman A., Gray K.S., Hogeman C.S., and Leuenberger U.A. Sympathetic chemoreflex responses in obstructive sleep apnea and effects of continuous positive airway pressure therapy. Chest 131 (2007) 1406-1413
21. Kelley E.E., Hock T., Khoo N.K., Richardson G.R., Johnson K.K., Powell P.C., Giles G.I., Agarwal A., Lancaster Jr. J.R., and Tarpey M.M. Moderate hypoxia induces xanthine oxidoreductase activity in arterial endothelial cells. Free Radic. Biol. Med. 40 (2006) 952-959
22. Lai C.J., Yang C.C., Hsu Y.Y., Lin Y.N., and Kuo T.B. Enhanced sympathetic outflow and decreased baroreflex sensitivity are associated with intermittent hypoxia-induced systemic hypertension in conscious rats. J. Appl. Physiol. 100 (2006) 1974-1982
23. Landmesser U., Spiekermann S., Preuss C., Sorrentino S., Fischer D., Manes C., Mueller M., and Drexler H. Angiotensin II induces endothelial xanthine oxidase activation: role for endothelial dysfunction in patients with coronary disease. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 943-948
24. Leung P.S., Lam S.Y., and Fung M.L. Chronic hypoxia upregulates the expression and function of AT(1) receptor in rat carotid body. J. Endocrinol. 167 (2000) 517-524
25. Li Q., Dale W.E., Hasser E.M., and Blaine E.H. Acute and chronic angiotensin hypertension: neural and nonneural components, time course, and dose dependency. Am. J. Physiol. 271 (1996) R200-R207
26. Li Y.L., Gao L., Zucker I.H., and Schultz H.D. NADPH oxidase-derived superoxide anion mediates angiotensin II-enhanced carotid body chemoreceptor sensitivity in heart failure rabbits. Cardiovasc. Res. 75 (2007) 546-554
27. Li Y.L., Li Y.F., Liu D., Cornish K.G., Patel K.P., Zucker I.H., Channon K.M., and Schultz H.D. Gene transfer of neuronal nitric oxide synthase to carotid body reverses enhanced chemoreceptor function in heart failure rabbits. Circ. Res. 97 (2005) 260-267
28. Li Y.L., Xia X.H., Zheng H., Gao L., Li Y.F., Liu D., Patel K.P., Wang W., and Schultz H.D. Angiotensin II enhances carotid body chemoreflex control of sympathetic outflow in chronic heart failure rabbits. Cardiovasc. Res. 71 (2006) 129-138
29. Marcus N.J., Olson Jr. E.B., Bird C.E., Philippi N.R., and Morgan B.J. Time-dependent adaptation in the hemodynamic response to hypoxia. Respir. Physiol. Neurobiol. 165 (2009) 90-96
30. Mohanram A., Zhang Z., Shahinfar S., Lyle P.A., and Toto R.D. The effect of losartan on hemoglobin concentration and renal outcome in diabetic nephropathy of type 2 diabetes. Kidney Int. 73 (2008) 630-636
31. Narkiewicz K., van de Borne P.J., Montano N., Dyken M.E., Phillips B.G., and Somers V.K. Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 97 (1998) 943-945
32. Olson S., Oeckler R., Li X., Du L., Traganos F., Zhao X., and Burke-Wolin T. Angiotensin II stimulates nitric oxide production in pulmonary artery endothelium via the type 2 receptor. Am. J. Physiol. Lung Cell Mol. Physiol. 287 (2004) L559-L568
33. Pediconi D., Martarelli D., Fontanazza A., and Pompei P. Effects of losartan and irbesartan administration on brain angiotensinogen mRNA levels. Eur. J. Pharmacol. 528 (2005) 79-87
34. Peng Y.J., Nanduri J., Yuan G., Wang N., Deneris E., Pendyala S., Natarajan V., Kumar G.K., and Prabhakar N.R. NADPH oxidase is required for the sensory plasticity of the carotid body by chronic intermittent hypoxia. J. Neurosci. 29 (2009) 4903-4910
35. Peng Y.J., Overholt J.L., Kline D., Kumar G.K., and Prabhakar N.R. Induction of sensory long-term facilitation in the carotid body by intermittent hypoxia: implications for recurrent apneas. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 10073-10078
36. Peng Y.J., and Prabhakar N.R. Effect of two paradigms of chronic intermittent hypoxia on carotid body sensory activity. J. Appl. Physiol. 96 (2004) 1236-1242
37. Peng Y.J., Yuan G., Ramakrishnan D., Sharma S.D., Bosch-Marce M., Kumar G.K., Semenza G.L., and Prabhakar N.R. Heterozygous HIF-1alpha deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J. Physiol. 577 (2006) 705-716
38. Phillips S.A., Olson E.B., Morgan B.J., and Lombard J.H. Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am. J. Physiol Heart Circ. Physiol. 286 (2004) H388-H393
39. Polotsky V.Y., Rubin A.E., Balbir A., Dean T., Smith P.L., Schwartz A.R., and O'Donnell C.P. Intermittent hypoxia causes REM sleep deficits and decreases EEG delta power in NREM sleep in the C57BL/6J mouse. Sleep Med. 7 (2006) 7-16
40. Prabhakar N.R., Kumar G.K., Chang C.H., Agani F.H., and Haxhiu M.A. Nitric oxide in the sensory function of the carotid body. Brain Res. 625 (1993) 16-22
41. Qadri F., Arens T., Schwartz E.C., Hauser W., and Dominiak P. Angiotensin-converting enzyme inhibitors and AT1-receptor antagonist restore nitric oxide synthase (NOS) activity and neuronal NOS expression in the adrenal glands of spontaneously hypertensive rats. Jpn. J. Pharmacol. 85 (2001) 365-369
42. Rey S., Del Rio R., Alcayaga J., and Iturriaga R. Chronic intermittent hypoxia enhances cat chemosensory and ventilatory responses to hypoxia. J. Physiol. 560 (2004) 577-586
43. Ritter O., Schuh K., Brede M., Rothlein N., Burkard N., Hein L., and Neyses L. AT2 receptor activation regulates myocardial eNOS expression via the calcineurin-NF-AT pathway. FASEB J. 17 (2003) 283-285
44. Schultz H.D., Li Y.L., and Ding Y. Arterial chemoreceptors and sympathetic nerve activity: implications for hypertension and heart failure. Hypertension 50 (2007) 6-13
45. Stepuro T.L., and Zinchuk V.V. Nitric oxide effect on the hemoglobin-oxygen affinity. J. Physiol. Pharmacol. 57 (2006) 29-38
46. Su K.H., Tsai J.Y., Kou Y.R., Chiang A.N., Hsiao S.H., Wu Y.L., Hou H.H., Pan C.C., Shyue S.K., and Lee T.S. Valsartan regulates the interaction of angiotensin II type 1 receptor and endothelial nitric oxide synthase via Src/PI3K/Akt signalling. Cardiovasc. Res. 82 (2009) 468-475
47. Sun M.K., and Reis D.J. Central neural mechanisms mediating excitation of sympathetic neurons by hypoxia. Prog. Neurobiol. 44 (1994) 197-219
48. Sun S.Y., Wang W., Zucker I.H., and Schultz H.D. Enhanced activity of carotid body chemoreceptors in rabbits with heart failure: role of nitric oxide. J. Appl. Physiol. 86 (1999) 1273-1282
49. Troncoso Brindeiro C.M., da Silva A.Q., Allahdadi K.J., Youngblood V., and Kanagy N.L. Reactive oxygen species contribute to sleep apnea-induced hypertension in rats. Am. J. Physiol Heart Circ. Physiol. 293 (2007) H2971-H2976
50. Usui M., Ichiki T., Katoh M., Egashira K., and Takeshita A. Regulation of angiotensin II receptor expression by nitric oxide in rat adrenal gland. Hypertension 32 (1998) 527-533
51. Zucker I.H., Schultz H.D., Patel K.P., Wang W., and Gao L. Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failure. Am. J. Physiol. Heart Circ. Physiol. 297 (2009) H1557-H1566